Stericycle, Inc. (NASDAQ:SRCL) – Jefferies Group cut their Q3 2017 earnings per share (EPS) estimates for shares of Stericycle in a report issued on Thursday. Jefferies Group analyst S. Dodge now forecasts that the business services provider will post earnings of $1.15 per share for the quarter, down from their prior estimate of $1.19. Jefferies Group currently has a “Buy” rating and a $108.00 price objective on the stock.
Several other equities research analysts have also recently issued reports on SRCL. BidaskClub cut shares of Stericycle from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Zacks Investment Research cut shares of Stericycle from a “buy” rating to a “hold” rating in a research report on Monday. Robert W. Baird cut shares of Stericycle from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $74.00 to $73.00 in a research report on Monday, May 15th. BMO Capital Markets started coverage on shares of Stericycle in a research report on Thursday, June 29th. They set a “market perform” rating and a $81.00 price target on the stock. Finally, Barclays PLC started coverage on shares of Stericycle in a research report on Thursday, April 13th. They set an “overweight” rating and a $100.00 price target on the stock. Four equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and six have given a buy rating to the company. Stericycle currently has an average rating of “Hold” and an average price target of $81.15.
ILLEGAL ACTIVITY NOTICE: “Stericycle, Inc. (SRCL) to Post Q3 2017 Earnings of $1.15 Per Share, Jefferies Group Forecasts” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.com-unik.info/2017/08/19/stericycle-inc-srcl-to-post-q3-2017-earnings-of-1-15-per-share-jefferies-group-forecasts-updated.html.
Stericycle (SRCL) opened at 77.06 on Monday. Stericycle has a one year low of $71.52 and a one year high of $90.43. The firm has a market capitalization of $6.57 billion, a price-to-earnings ratio of 40.16 and a beta of 0.13. The stock has a 50 day moving average of $76.90 and a 200 day moving average of $80.64.
Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, August 3rd. The business services provider reported $1.15 EPS for the quarter, topping the consensus estimate of $1.13 by $0.02. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. The firm had revenue of $917.70 million for the quarter, compared to analyst estimates of $902.81 million. During the same period in the prior year, the business posted $1.18 EPS. The business’s revenue for the quarter was up 2.9% compared to the same quarter last year.
Several hedge funds have recently bought and sold shares of SRCL. Kernodle & Katon Asset Management Group LLC purchased a new stake in Stericycle during the first quarter worth about $100,000. Heritage Trust Co purchased a new stake in Stericycle during the first quarter worth about $124,000. Pacer Advisors Inc. raised its stake in Stericycle by 8.4% in the second quarter. Pacer Advisors Inc. now owns 1,880 shares of the business services provider’s stock worth $143,000 after buying an additional 145 shares in the last quarter. Invictus RG purchased a new stake in Stericycle during the first quarter worth about $145,000. Finally, Morgan Dempsey Capital Management LLC raised its stake in Stericycle by 2.6% in the first quarter. Morgan Dempsey Capital Management LLC now owns 1,902 shares of the business services provider’s stock worth $158,000 after buying an additional 48 shares in the last quarter. Institutional investors own 95.16% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
What are top analysts saying about Stericycle Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Stericycle Inc. and related companies.